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a b s t r a c t
The colonisation of clinical and industrial surfaces with pathogenic microorganisms has prompted
increased research into the development of effective antibacterial and antifouling coatings. There is
evidence that implanted biomedical surfaces coated with metallic silver can be inactivated by physiological ﬂuids, thus reducing the bioactivity of the coating. In this work, we report the bioﬁlm inhibition of
Staphylococcus epidermidis using a room temperature processed silver doped perﬂuoropolyether-urethane
coating. The release of silver ions from these ﬂuoropolymers over a six-day period inhibited bacterial
encrustation – as observed by scanning electron microscopy (SEM). X-ray photoelectron spectroscopy
(XPS) analysis indicated differences in carbon, ﬂuorine and sodium surface composition between silver
doped and undoped ﬂuoropolymers after exposure to nutrient rich media. These silver doped perﬂuoropolyether coatings also exhibited antibacterial activity against methicillin-resistant Staphylococcus
aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii; suggesting potential use in preventing transmission of pathogenic and opportunistic microbes on environmental surfaces
in healthcare facilities. The broad-spectrum antibacterial activity of these silver release coatings may be
exploited on biomaterials surfaces to combat the development of resistant Gram-negative Enterobacteriaceae that can occur during prophylactic treatment for urinary tract infections.
© 2009 Elsevier B.V. All rights reserved.

1. Introduction
Bacteria such as Staphylococcus aureus have shown adaptibility
to changing environments in the healthcare setting, but also more
recently in the wider community [1–3]. Opportunistic pathogens
such as S. aureus and Pseudomonas aeruginosa, along with other
bacteria, can develop resistance through an elaborate array of
mechanisms. These include modiﬁcation of the target protein or
binding site, enzymatic destruction of antibacterial agents, active
efﬂux of drugs from the bacterial cell or by acquisition of genetic
material from other resistant strains [4,5]. The emergence of bacterial resistance often occurs shortly after the introduction of a new
antibacterial agent. An increase in resistance can be observed by an
elevated minimum inhibitory concentration (MIC) of the antibacterial agent [6]. This can be exempliﬁed by the rapid emergence of
Enterococcus faecium resistance to anti-VRE/MRSA antibiotics, such
as linezolid [7].

∗ Corresponding author. Tel.: +353 1 4024778; fax: +353 1 4024989.
E-mail address: declan.mccormack@dit.ie (D.E. McCormack).

The reduction in the number of available antibacterial therapies
for the treatment of multi-drug resistant pathogens, has resulted
in a reversion to older antimicrobial agents, such as silver [8]. In
medical terms, silver is the antimicrobial metal best known for
its broad-spectrum activity against intractable infectious microorganisms, including antibiotic resistant strains [8]. The multiple
modes of action of silver include binding with cell DNA, inhibiting enzymes that mediate respiration and reacting with sensitive
thiol groups on bacterial proteins – thereby destroying the normal
biological activity of the protein [9]. The antimicrobial properties
of nanosilver loaded ﬁlter paper against Escherichia coli have been
recently studied [10]. The use of medical device coatings as release
or delivery vehicles for these biocidal silver ions has received signiﬁcant attention recently. Silver ion release from sol–gel coatings
has demonstrated antibacterial activity against S. aureus and E. coli
[11–12]. Nanosilver coated fabric inhibited the growth of the Gramnegative bacterium E. coli [13]. Silver coated PTFE surfaces have
shown antibacterial activity, but direct coating of silver onto a surface can be inactivated by biological anions with subsequent surface
encrustation [14,15]. Previously reported studies have shown the
beneﬁt of silver impregnation in place of metallic silver deposition
[16], although traditional techniques for the deposition or impregnation of silver employ high temperature processing, which limits
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substrate choice and increases costs [11,16]. In addition, one of the
factors governing silver ion release from a coating matrix is the
hydrophilicity of the coating [17]. Therefore, coatings with purely
hydrophobic components will have limited water afﬁnity and consequently a low silver release. This route may be ineffective, as
coatings that release low levels of silver may select for resistance
[18].
Polyether polyurethanes are low friction, biocompatible, elastomeric polymers that have been investigated as anti-fouling and
biomedical coatings [19]. However, they are prone to biodegradation and environmental stress-cracking due to interactions
with lysomal oxygen-free radicals and transition metal ions from
implanted devices [20]. Polyether urethanes containing silver
nanoparticles have shown improved biostability due to the free
radical scavenging ability of the silver nanoparticles [21]. Modiﬁcation of these polymers with ﬂuorocarbons has been reported to
improve biostability as ﬂuorocarbons are stable against hydrolysis
and oxidation [22].
In this work, we present the preparation, antibacterial activity
and surface analysis of silver doped perﬂuoropolyether-urethane
coatings. Silver ion release from these ﬂuorinated dispersions
exhibited signiﬁcant antibacterial activity against MRSA, E. coli,
P. aeruginosa and Acinetobacter baumannii. SEM was employed to
examine the surfaces of the doped and undoped coatings after
exposure to a bioﬁlm-positive strain of S. epidermidis. XPS surface analysis provided information on the elemental and chemical
composition of the coatings before and after exposure to different
media. The surface composition of the silver doped ﬂuoropolymers did not display signiﬁcant changes in surface chemistry after
six days bacterial exposure. In contrast, the blank ﬂuoropolymers
showed increased surface carbon and sodium levels, with a reduction in ﬂuorinated content. The antibacterial capacity of the silver
doped ﬂuoropolymers was challenged by exchanging the nutrient
rich medium every 24 h. After six days bacterial exposure, the supernatant broth still contained enough bio-active silver ions to inhibit
planktonic S. epidermidis. In summary, these room temperature processed coatings may be employed in reducing contamination and
biofouling on short-term indwelling devices and environmental
surfaces.
2. Experimental
Silver doped ﬂuoropolymers were prepared by the addition of
a silver nitrate salt to an anionic perﬂuoropolyether (PFPE) urethane polymer, Fluorolink® P56 (Mw ≈ 20,000, Solvay) [23]. 55 mg
(0.3 mmol) silver nitrate (Aldrich) was dissolved by sonication in
2.5 ml (0.2 mol) de-ionised water containing 2.5 g polyaziridine
cross-linker CX-100 (Neoresins). This solution was slowly added
to the anionic ﬂuorinated dispersion (95 g) under stirring. A silver nitrate free control was similarly prepared. The silver doped
ﬂuoropolymers were prepared in amber glassware to prevent photoreduction of the silver ions. The resulting silver doped and
undoped polymers were applied to pre-cleaned tin coated steel and
glass substrates using a 100 m ﬁlm applicator and cured at room
temperature for 4 h, resulting in nominal ﬁlm thickness of approximately 30 m. The prepared coatings showed no tendency towards
delamination or cracking before or after testing.
2.1. Instrumentation
The release of silver from the coatings was determined by GFAAS using a Varian 110 Spectrometer equipped with a silver hollow
cathode lamp. Microanalysis of the coatings was assessed using a
Jeol 8600 scanning electron microscope (SEM). The samples were
mounted on stubs and gold coated for SEM imaging at 10 KeV.

XPS analysis employed an ESCALAB Mk II spectrometer equipped
with a twin anode X-ray source was used to analyse the surface
composition (≈10 nm) of the ﬂuoropolymers and silver doped ﬂuoropolymers. The instrument was equipped with a twin anode X-ray
source (AlK␣/MgK␣) and an Alpha 110 analyser. In this work the
twin anode AlK␣ X-ray source (h = 1486.6 eV) was used at 300 W
(15 kV × 20 mA). Quantitative surface chemical analyses were calculated from the high resolution, core level spectra following the
removal of a non-linear (Shirley) background. All spectrum binding
energies were referenced to the hydrocarbon C 1s peak at 285 eV to
correct for electrostatic charging effects during acquisition. Sample
mounting for XPS analysis was achieved by ﬁxing a specimen to a
VG sample stub using double sided adhesive tape.
2.2. Silver release
Silver doped perﬂuoropolyether coated glass substrates
(25 cm2 ) were immersed in 50 ml of physiological buffered saline
(PBS) at 37 ◦ C initially for 1 h, followed by six successive 24 h
immersion periods. Fresh media was used for each immersion
period. Silver values are expressed in ppb (g/L). The ﬂuids were
collected after each immersion period and analysed using GF-AAS.
2.3. Antibacterial activity
The antibacterial activity of the silver doped and undoped
ﬂuoropolymers, against a selection of Gram-positive and Gramnegative strains, was determined using a modiﬁed version of the
Japanese standard (JIS Z 2801). These bacterial strains include MRSA
(clinical isolate) S. aureus (ATCC 25922), P. aeruginosa (ATCC 27853),
A. baumannii (clinical isolate) and a bioﬁlm-positive strain of S. epidermidis (CSF 41498). Stock cultures of the bacteria were grown on
plate count agar (PCA-3 w/v% tryptone, 1 w/v% glucose, 2.5 w/v%
yeast, 9 w/v% agar, Oxoid). The organisms were grown overnight
in nutrient rich broth to give a concentration of approximately
108 CFU/ml. These were diluted one in a hundred with maximum
recovery diluent (MRD – 1 w/v% peptone, 8.5 w/v% NaCl, Oxoid) to
give a working culture of approximately 106 CFU/ml. Doped and
undoped coatings (25 cm2 ) were inoculated with 400 l of the
working bacterial cultures and incubated at 37 ◦ C overnight. The
coatings were then agitated with MRD (20 ml) in sterile stomacher
bags. To determine the number of colonies, the MRD was serially
diluted tenfold and the resulting dilutions plated (100 l) onto plate
count agar (PCA) for overnight incubation at 37 ◦ C.
2.4. Bioﬁlm growth
Silver doped and undoped perﬂuorinated polymers were
applied to pre-cleaned tin panels and allowed to cure for 4 h. Plastic wells were glued to the surface of the coatings using an epoxy
ﬁxative (Epoﬁx) and left to cure for 24 h (Fig. 1). 5 ml of tryptic soy
broth (TSB – tryptone 17 g/L, soy peptone 3 g/L, NaCl 5 g/L, dipotassium hydrogen phosphate 2.5 g/L, dextrose 2.5 g/L), supplemented
with 0.25% glucose was added to the wells. 50 l of approximately
108 CFU/ml S. epidermidis (CSF 41498) culture was added to the glucose modiﬁed TSB broth and the resulting bacterial broth poured
into the wells and incubated for 24 h at 37 ◦ C. The TSB medium
was removed and replaced with fresh glucose modiﬁed TSB every
24 h and subsequently incubated at 37 ◦ C. This process was repeated
for six days. The daily exchange of nutrient rich media is useful in
challenging the antibacterial capacity of the coating over the six
days. Finally, the medium was decanted off and the coatings washed
twice with sterile water. SEM was used to examine the surface of
the coatings for the presence of any extraneous matter. Detailed
surface elemental and chemical composition of the ﬂuoropolymer
coatings was obtained using XPS.
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Fig. 3. Ag 3d XPS surface spectra of as-prepared Ag doped ﬂuoropolymer coating.

Fig. 1. Non-cumulative release of silver into fresh PBS media from Ag doped ﬂuoropolymer (determined by GF-AAS).

3. Results and discussion
3.1. Silver release
The incorporation of silver salts into hydrophobic sol–gel coatings has been reported to initially release high levels of silver ions,
followed by a more gradual and sustained release proﬁle [12]. In this
work, the release of silver ions into PBS solution at 37 ◦ C over six
days is depicted in Fig. 1. Initially after 1 h, approximately 300 ppb
was released into the PBS solution, followed by a more sustained
release proﬁle for six days. As the ﬁrst 6 h after device implantation
is reported as being critical in reducing initial bacterial adhesion
[24], this initial high release of a broad-spectrum antibacterial agent
is favourable. XPS was employed to examine the surface composition of the coatings before and after exposure to external media.
XPS is a useful analytical tool in bioengineering for determining
the atomic composition of speciﬁc functional groups in the ﬁrst
10 nm of a surface coating. This technique was previously employed
to determine the surface composition of antibacterial furanones
[25]. XPS measurements of the silver doped coatings before and
after immersion in PBS indicated the appearance of a urethane
related peak at the coating surface following immersion (Fig. 2).
This speciﬁc peak at 532 eV is associated with the carbonyl oxygen of (–NH–(C O)–O–) [23]. This migration of polar species has
been previously reported with polyethylene glycol (PEG) modiﬁed
PFPE coatings [26]. Such polymers demonstrated surface adaptable properties when immersed in a polar medium such as water.
As PFPE molecules migrate to the air interface, the PEG molecules
also migrate. As a result, when the PEG modiﬁed PFPE polymer is
immersed in water the more polar PEG molecules stratify to the
air interface [26]. In this work, we observed a similar phenomenon

with the stratiﬁcation of the urethane species to the air-interface
after immersion in aqueous media. The presence of silver in the
as-prepared surface coating can be conﬁrmed by the presence of
the peak at 368.2 eV [12]. The presence of silver in the coating was
conﬁrmed by XPS analysis with a percentage atomic concentration
of 0.04% (Fig. 3). No surface silver was observed on the coating after
exposure to PBS. The daily exchange of anionic species such as chlorides and phosphates in the PBS would have depleted the available
surface silver, by the possible formation of AgCl and Ag3 PO4 precipitates on the coating surface [27]. No visible precipitates were
observed in the PBS solutions after silver release. No surface phosphorus was observed by XPS and the percentage atomic sodium and
chlorine was 3.2% and 0.91%, respectively.
3.2. Antibacterial activity
The release of silver ions from the perﬂuorinated coatings had
a signiﬁcant antibacterial effect against MRSA (clinical isolate) S.
aureus (ATCC 25922), P. aeruginosa (ATCC 27853), A. baumanii (clinical isolate) and a bioﬁlm-positive strain of S. epidermidis (CSF
41498) (Fig. 4). Overnight incubation of the inoculated coatings
resulted in approximately 99% (>103 CFU/ml), reduction in bacterial
colonies compared to undoped samples after 24 h. The broadspectrum activity suggests the use of these hygienic coatings in
preventing environmental contamination on hand rails, bedside
rails, door handles and other transmissible surfaces in healthcare
environments. This is important as patients who are infected with
healthcare and community associated microbes may shed bacteria onto fomites such as those found in hospitals, nursing homes,
childcare facilities, prisons and public transport [28]. In addition, as
silver ion release is governed by water diffusion through the coating
[17], the use of water as a cleaning agent, in-place of standard antiseptics and detergents, may be sufﬁcient to generate a bio-active
surface.
3.3. Bioﬁlm growth

Fig. 2. O 1s XPS surface spectra of silver doped ﬂuoropolymer before and after
immersion in PBS.

Bioﬁlms are complex assemblages of microorganisms that bind
to host surfaces that can cause device failure and pathogenesis. Sessile bacterial cells provide diffusion barriers to prophylactic treatment by binding with antibiotics. Furthermore, the close proximity
of bacterial cells facilitates the spreading of antibiotic resistant
plasmids (extra-chromosomal material) thus altering antimicrobial
susceptibility [29]. The bacterial cells that reside near the substratum are in anoxic regions and are thus slow growing, leading to an
intrinsic tolerance to antibiotic dosage – relative to the aerobic cells
in the peripheral layers of the bioﬁlm [30]. S. epidermidis is the most
common bacterium isolated from medical devices such as vascular
catheters, prosthetic implants and intrauterine devices [27]. Several strategies have been investigated in preventing bioﬁlm growth
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Fig. 4. Antibacterial activity of Ag doped perﬂuoropolyether coatings against (A) S. aureus (ATCC25922) (B) MRSA (clinical isolate) (C) P. aeruginosa (ATCC 27853) (D) A.
baumanii (clinicalisolate). Left plate: Silver doped ﬂuoropolymer. Right plate: undoped ﬂuoropolymer. (JIS Z 2801).

on indwelling biomaterials [31]. One of these techniques involves
the functionalisation of the indwelling surfaces; to include active
antibacterial agents on the biomaterial surface. Antibiotics function by targeting speciﬁc biomolecular pathways and as a result
have a propensity for the development of resistance to prophylactic treatment. This emergence of antibiotic resistance has prompted
a resurgence in the use of biocidal metals, such as silver.
Due to the broad-spectrum activity at relatively low concentrations, silver technology has been employed in various applications
such as medical devices [32], household appliances and water
treatment [33]. Low concentrations (<35 ppb) are reported to be
bactericidal [34], whilst higher concentrations between 1 ppm and
10 ppm may cause damage to human cells, ranging from low
localised toxicity to conditions like argyria in higher doses (>4–6 g
in the body) [35]. Histopathologic examination of silver coated
megaprostheses in humans showed no signs of local or systemic
side-effects at concentrations up to 1627 ppb [36].
Silver impregnated catheters have been reported to demonstrate
superior inhibition of bacterial colonisation than antibiotic impregnated catheters [37,38]. The effect of silver ions on bioﬁlms has been
recently reported [39,40]. Addition of silver ions at a concentration of 50 ppb to an existing bioﬁlm had a diffusion limiting effect,
as sessile bacteria can sequester the silver ions into the anionic

polysaccharide components, reducing penetration and thus rendering them inactive [40]. Therefore, it is crucial to inhibit bioﬁlm
formation by reducing this initial surface bacterial adhesion [24].
In biological systems, the interaction between S. epidermidis bacterial cells and surfaces are mediated by hydrophobic forces [41]. In
particular, the presence of hydrophobic chains in the ﬂuoropolymer
may facilitate the microbial hydrophobic attraction of Staphylococcal bacterial cells to the biomaterial surface. It has been reported
that a large quantity of microbial pathogens are dependent on
hydrophobic interactions for successful colonisation of host substrates [42].
In this study, the effect of silver ion release on surface
encrustation can be observed in the SEM images in Fig. 5. The
blank perﬂuoropolyether-urethane coating is covered in adherent bacterial deposits (Fig. 5a). Silver ion release from the doped
ﬂuoropolymer reduced the colonisation of extraneous matter on
the coating surface (Fig. 5b). Additional XPS elemental and chemical composition of the coatings indicated differences in surface
chemical composition (10 nm) between the ﬂuoropolymer and the
silver doped ﬂuoropolymer after six days exposure to S. epidermidis bacterial broth. The difference in percentage atomic carbon
(38.9% to 50.8%) (Fig. 6) and consequent reduction in atomic ﬂuorine (35.2% to 17.5%) (Fig. 7) between silver doped and undoped

Fig. 5. SEM of ﬂuoropolymer coating (a) and silver doped ﬂuoropolymer (b) after six days S. epidermidis, bacterial broth incubation.
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Table 1
Summary of XPS data, before and after exposure to S. epidermidis broth for six days.

Fig. 6. C 1s XPS surface spectra of ﬂuoropolymer and silver doped ﬂuoropolymer
after six days S. epidermidis bacterial broth incubation.

perﬂuorinated coating may be attributed to bacterial accumulation
on the ﬂuoropolymer surface. The peak at 293.2 eV corresponding
to –C*F2 –O–CF3 is present in the as-prepared ﬂuoropolymer but
disappears after bacterial exposure (Fig. 6). Incorporation of a silver
salt in the ﬂuoropolymer maintained this functional group at the
air-interface, by inhibiting planktonic bacterial adhesion and subsequently reducing surface encrustation. Furthermore, there was a
reduction in percentage atomic sodium (Fig. 8), potassium, chlorine and nitrogen on the surface of the silver doped ﬂuoropolymer
coating (Table 1). The percentage of atomic silver present in the
as-prepared silver doped ﬂuoropolymer was 0.04% but no surface
silver was detected by XPS post bacterial incubation, analogous to
PBS elution. In addition to the broad-spectrum antimicrobial activity against planktonic strains, silver ion elution reduced bacterial
colonisation on the coating surface. Furthermore, as bioﬁlm fragments may detach and the seed into surrounding ﬂuids [43], it is
important to inhibit any free ﬂoating or planktonic bacteria. After
six days bacterial exposure, the supernatant broth still contained
enough bio-active silver ions to inhibit planktonic S. epidermidis

Coating type

% XPS elemental composition
Ag
C
F

O

Na

Initial
ﬂuoropolymer
Initial Ag
ﬂuoropolymer
Fluoropolymer
after six days
bacterial
exposure
Ag ﬂuoropolymer
after six days
bacterial
exposure

0

29.2

52

17

0

0.04

35.5

44.8

17

0

0

50.8

17.5

19

4.7

0

38.9

35.2

18

2.6

Fig. 9. Antibacterial activity of bioﬁlm extraction media against planktonic S. epidermidis (CSF 41498) after exposure to silver doped ﬂuoropolymer (a) ﬂuoropolymer
(b).

(Fig. 9). Furthermore, these silver ion releasing coatings may be beneﬁcial in reducing mineral precipitation and the associated bioﬁlm
formation, by reducing the number of viable cells from the urease
producing Proteus mirabilis.
4. Conclusion

Fig. 7. F 1s XPS surface spectra of ﬂuoropolymer and silver doped ﬂuoropolymer
after six days S. epidermidis bacterial broth incubation.

Fig. 8. Na 1s XPS surface spectra of ﬂuoropolymer and silver doped ﬂuoropolymer
after six days S. epidermidis bacterial broth incubation.

The tremendous resistance of bioﬁlms to conventional prophylactic agents has prompted a great deal of research on
biomaterial surfaces and coatings that can reduce bacterial
colonisation with subsequent device removal. In this paper,
we propose the use of a room temperature processed silver
release perﬂuoropolyether-urethane coating, in reducing the surface colonisation on biomedical and environmental surfaces. XPS
analysis provided useful information on the surface composition
of the coatings before and after exposure to PBS and S. epidermidis
bacterial broth. The silver free ﬂuoropolymer exhibited higher carbon and sodium content, with a consequent reduction in ﬂuorine
content, in comparison to the silver containing ﬂuoropolymer. The
release of silver ions from these ﬂuorinated coatings demonstrated
antibacterial activity against MRSA, P. aeruginosa, A. baumannii and
S. epidermidis. There was approximately 99% reduction in the number of bacterial colonies in comparison to the control ﬂuoropolymer.
The antibacterial capacity of these coatings was challenged by
the daily exchange of nutrient rich medium. These antibacterial
coatings can also be used to deliver alternative metal ions (Zn,
Cu) to inhibit fungal/algal growth and contamination on environmental surfaces. As silver is a broad-spectrum antimicrobial,
these short-term indwelling coatings have the potential to combat resistant Gram-negative Enterobacteriaceae that can occur after
ﬂuoroquinolone, cephalosporin or glycopeptide administration for
urinary tract infections. The low temperature processing requirements of these silver release coatings makes them suitable for the
judicious protection of various surfaces against bacterial infection.
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